Evidence map›Paper›PMID 14566327›Full record

ArticleEMBO reports2003

Pre-TCR-triggered ERK signalling-dependent downregulation of E2A activity in Notch3-induced T-cell lymphoma.

Claudio Talora, Antonio F Campese, Diana Bellavia, Monica Pascucci, Saula Checquolo, Manuela Groppioni, Luigi Frati, Harald von Boehmer, Alberto Gulino, Isabella Screpanti

Open access · bronzeAbstract read
In one paragraph

Article in EMBO reports, 2003. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 26 papers.

0numbers the graph read from it
0cells of the map it votes in
26citing papers in PubMed
2.6field-weighted citation impact, top 10% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

26 citing papers in PubMed, 70 citations in OpenAlex.

  1. Review
  2. Article
  3. Review
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Review
  18. Notch signaling in leukemia.Annual review of pathology · 2008
    Review
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors at 2 institutions in 2 countries.

Claudio TaloraLaboratory of Molecular Pathology, Department of Experimental Medicine and Pathology, University La Sapienza, Viale Regina Elena 324, 00161 Rome, Italy.
Antonio F Campese
Diana Bellavia
Monica Pascucci
Saula Checquolo
Manuela Groppioni
Luigi Frati
Harald von Boehmer
Alberto Gulino
Isabella Screpanti
Sapienza University of Rome · ITDana-Farber Cancer Institute · US

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Notch and basic helix-loop-helix E2A pathways specify cell fate and regulate neoplastic transformation in a variety of cell types. Whereas Notch enhances tumorigenesis, E2A suppresses it. However, whether and how Notch and E2A interact functionally in an integrative mechanism for regulating neoplastic transformation remains to be understood. It has been shown that Notch3-induced T-cell leukaemia is abrogated by the inactivation of pTalpha/pre-T-cell antigen receptor (pre-TCR). We report here that Notch3-induced transcriptional activation of pTalpha/pre-TCR is responsible for the downregulation of E2A DNA binding and transcriptional activity. Further, the E2A messenger RNA and protein levels remain unaltered but the E2A inhibitor Id1 expression is augmented in thymocytes and T lymphoma cells derived from Notch3 transgenic mice. The increase in Id1 expression is achieved by pre-TCR-induced extracellular-signalling-regulated kinase 1/2. These observations support a model in which the upregulation of pre-TCR signalling seems to be the prerequi-site for Notch3-induced inhibition of E2A, thus leading to the development of lymphoma in Notch3 transgenic mice.

Indexed as

Repressor ProteinsAnimalsDown-RegulationHelix-Loop-Helix MotifsInhibitor of Differentiation Protein 1Lymphoma, T-CellMiceMitogen-Activated Protein KinasesProto-Oncogene ProteinsReceptor, Notch3Receptor, Notch4Receptors, Antigen, T-CellReceptors, Cell SurfaceReceptors, NotchSignal TransductionTranscription FactorsIdb1 protein, mouseInhibitor of Differentiation Protein 1Mitogen-Activated Protein KinasesNotch3 protein, mouseNotch4 protein, mouseProto-Oncogene ProteinsReceptor, Notch3Receptor, Notch4Receptors, Antigen, T-CellReceptors, Cell SurfaceReceptors, NotchRepressor ProteinsTranscription Factors

Identifiers

PMID14566327
PMCPMC1326383
OpenAlexW2032534720

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.